Lyra Therapeutics, Inc. Profile Avatar - Palmy Investing

Lyra Therapeutics, Inc.

Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo techn…

Biotechnology
US, Watertown [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Lyra Therapeutics, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of LYRA's Analysis
CIK: 1327273 CUSIP: 55234L105 ISIN: US55234L1052 LEI: - UEI: -
Secondary Listings
LYRA has no secondary listings inside our databases.